Each tablet contains: Irbesartan 150 mg and Hydrochlorothiazide 12.5 mg.
Irbesartan is a specific competitive antagonist of Angiotensin-II receptor (AT1 subtype). The parent drug is orally active and does not require biotransformation.
Hydrochlorothiazide is a moderately potent diuretic for treating hypotension. Its main action is the inhibition of the NaCl reabsorption in the distal convoluted tubules of the kidney.
Other Services
Country
Support
Account
Sign Out